1-10 of 10
Montreh Tavakkoli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD5 Expression in Mature T Cell Lymphoma

Miao Cao, Montreh Tavakkoli, Elise A. Chong, Jordan S Carter, Marco Ruella, Daniel J. Landsburg, Sunita D. Nasta, Jakub Svoboda, Stephen J Schuster, Stefan K. Barta
Journal: Blood
Blood (2023) 142 (Supplement 1): 6195.
https://doi.org/10.1182/blood-2023-188043
Published: 2023
Journal Articles

Impact of Large Cells and Ki-67% on Outcomes in Patients with Newly Diagnosed Marginal Zone Lymphoma - Results from a Multicenter Cohort Study

Narendranath Epperla, Natalie S. Grover, Kaitlin Annunzio, Marcus P Watkins, Pallawi Torka, Reem Karmali, Andrea Carolina Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Nancy L. Bartlett, Geoffrey P. Shouse, Adam J Olszewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 266.
https://doi.org/10.1182/blood-2023-185152
Published: 2023
Journal Articles

Impact of Diagnosis to Treatment Interval on Outcomes in Patients with Newly Diagnosed Marginal Zone Lymphoma - a US Multisite Study

Narendranath Epperla, Kaitlin Annunzio, Geoffrey P. Shouse, Natalie S. Grover, Pallawi Torka, Marcus P Watkins, Andrea Carolina Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett, Adam J Olszewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 5159.
https://doi.org/10.1182/blood-2023-185205
Published: 2023
Journal Articles

Impact of Maintenance Rituximab Following First-Line Systemic Therapy on Outcomes in Patients with Marginal Zone Lymphoma: Real-World Evidence from 10 US Centers

Narendranath Epperla, Kaitlin Annunzio, Geoffrey P. Shouse, Natalie S. Grover, Pallawi Torka, Marcus P Watkins, Andrea Carolina Anampa-Guzmán, Timothy S. Oh, Heather Reves, Montreh Tavakkoli, Emily Hansinger, Beth Christian, Colin Thomas, Stefan K. Barta, Praveen Ramakrishnan Geethakumari, Reem Karmali, Nancy L. Bartlett, Adam J Olszewski
Journal: Blood
Blood (2023) 142 (Supplement 1): 5147.
https://doi.org/10.1182/blood-2023-185182
Published: 2023
Journal Articles

Epichaperome Abundance Predicts Response to the Epichaperome Inhibitor, Puh-71, in Acute Myeloid Leukemia

Montreh Tavakkoli, MA,MD, Justin D. Kaner, MD, Sharma Sahil, PhD, Tony Taldone, PhD, Swathi Merugu, PhD, Gabriela Chiosis, PhD, Gail J. Roboz, MD, Monica L. Guzman, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5145.
https://doi.org/10.1182/blood-2019-125175
Published: 2019
Journal Articles

PTPN11 Mutated Acute Myeloid Leukemia (AML) Features an Abundant Epichaperome Network and Is Sensitive to the Epichaperome Inhibitor PU-H71

Justin D. Kaner, MD, Montreh Tavakkoli, MA,MD, Lisa Toudic, Brett M. Stevens, PhD, Craig T Jordan, PhD, Tony Taldone, PhD, Gabriela Chiosis, PhD, Ellen K. Ritchie, MD, Pinkal Desai, MDMPH, Michael B. Samuel, MD, Sangmin Lee, MD, Gail J. Roboz, MD, Monica L. Guzman, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3935.
https://doi.org/10.1182/blood-2019-128276
Published: 2019
Journal Articles

The Significance of Leukocytosis in Malignancies: A Novel Paradigm Between Leukocytosis, G-CSF, Myeloid-Derived Suppressor Cells and Prognosis

Montreh Tavakkoli, MD MA, Cy Wilkins, MD, Jodi V Mones, MD, Michael J. Mauro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4944.
https://doi.org/10.1182/blood-2018-99-117484
Published: 2018
Journal Articles

Targeting CD99 in T-Cell Neoplasms with Monoclonal Antibodies

Montreh Tavakkoli, MA, Dong H. Lee, MD, Benjamin Durham, MD PhD, Stephen S. Chung, MD, Christopher Y. Park, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 2749.
https://doi.org/10.1182/blood.V126.23.2749.2749
Published: 2015
Journal Articles

CD99 Is a Therapeutic Target on Disease Initiating Stem Cells in Acute Myeloid Leukemia and the Myelodysplastic Syndromes

Stephen S. Chung, MD, Montreh Tavakkoli, BS, Virginia M. Klimek, MD, Christopher Y. Park, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3760.
https://doi.org/10.1182/blood.V124.21.3760.3760
Published: 2014
Journal Articles

CD99 Is a Therapeutic Target On Disease Stem Cells In Acute Myeloid Leukemia and The Myelodysplastic Syndromes

Stephen S. Chung, MD, Montreh Tavakkoli, BS, Sean M. Devlin, PhD, Christopher Y. Park, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2891.
https://doi.org/10.1182/blood.V122.21.2891.2891
Published: 2013